These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 19350775)

  • 21. [Independent clinical trials are imperative].
    Gøtzsche PC
    Ugeskr Laeger; 2005 Apr; 167(14):1491-4. PubMed ID: 15887740
    [No Abstract]   [Full Text] [Related]  

  • 22. Ethics and industry-sponsored research.
    Kuebler C; Nimmo WS; von R; Gillings D; Morgan AT; Kendle C; Covington PS
    CMAJ; 2002 Mar; 166(5):579-80; author reply 582. PubMed ID: 11898930
    [No Abstract]   [Full Text] [Related]  

  • 23. Industry-sponsored pharmaceutical trials and research ethics boards: are they cloaked in too much secrecy?
    Ferris LE
    CMAJ; 2002 May; 166(10):1279-80. PubMed ID: 12041844
    [No Abstract]   [Full Text] [Related]  

  • 24. Ethical issues in the relationships involving medicine and industry.
    Thomas PS; Tan KS; Yates DH
    Intern Med J; 2005 Dec; 35(12):732. PubMed ID: 16313554
    [No Abstract]   [Full Text] [Related]  

  • 25. Comments on 'The potential for bias in the reporting of industry sponsored clinical trials' by Stephen Pyke et al. and 'Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry sponsored clinical trials' by James Matcham et al. Pharmaceutical Statistics.
    Campbell MJ
    Pharm Stat; 2011; 10(1):80-1. PubMed ID: 21275038
    [No Abstract]   [Full Text] [Related]  

  • 26. Conflict of interest in the debate over calcium-channel antagonists.
    Opie L
    N Engl J Med; 1998 Jun; 338(23):1696-7; author reply 1697-8. PubMed ID: 9616064
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluating solutions to sponsorship bias.
    Doucet M; Sismondo S
    J Med Ethics; 2008 Aug; 34(8):627-30. PubMed ID: 18667655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Industry sponsored bias in cost effectiveness analyses.
    John-Baptiste A; Bell C
    BMJ; 2010 Oct; 341():c5350. PubMed ID: 20943724
    [No Abstract]   [Full Text] [Related]  

  • 29. [Drug industry influence on hypertension treatment trials].
    Waeber B; Burnier M; Pechère-Bertschi A
    Rev Med Suisse; 2005 Sep; 1(32):2067-8. PubMed ID: 16238226
    [No Abstract]   [Full Text] [Related]  

  • 30. Industry funded clinical trials: bias and quality.
    Del Parigi A
    Curr Med Res Opin; 2012 Jan; 28(1):23-5. PubMed ID: 22103762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How pharmaceutical industry funding affects trial outcomes: causal structures and responses.
    Sismondo S
    Soc Sci Med; 2008 May; 66(9):1909-14. PubMed ID: 18299169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bias and sponsored research.
    Kaufman SR
    Ophthalmology; 2008 Feb; 115(2):412-3; author reply 413. PubMed ID: 18243910
    [No Abstract]   [Full Text] [Related]  

  • 33. US government is funding fewer trials as number of industry sponsored trials grows.
    Dyer O
    BMJ; 2015 Dec; 351():h6893. PubMed ID: 26684014
    [No Abstract]   [Full Text] [Related]  

  • 34. Medicine and the pharmaceutical industry.
    Baxter P
    Dev Med Child Neurol; 2006 Aug; 48(8):627. PubMed ID: 16836771
    [No Abstract]   [Full Text] [Related]  

  • 35. How skeptical should we be about industry-sponsored studies?
    Meador KJ
    Neurology; 2007 Apr; 68(15):1238; author reply 1238. PubMed ID: 17420417
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical trials: the pitfalls of interpretation.
    Lokhandwalla Y; Dalvi B
    Issues Med Ethics; 1998 Apr; 6(2):47-8. PubMed ID: 15011700
    [No Abstract]   [Full Text] [Related]  

  • 37. [A clear winner and two losers].
    Furberg C
    Lakartidningen; 2009 Mar 25-31; 106(13):953. PubMed ID: 19441201
    [No Abstract]   [Full Text] [Related]  

  • 38. Conflicts of interest in dermatology.
    Williams HC; Naldi L; Paul C; Vahlquist A; Schroter S; Jobling R
    Acta Derm Venereol; 2006; 86(6):485-97. PubMed ID: 17106594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical researchers and pharmaceutical industry. Dangerous liaisons].
    Roos JC
    Ned Tijdschr Geneeskd; 1999 Aug; 143(32):1668-71. PubMed ID: 10494304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reporting bias in industry-supported medication trials presented at the American Psychiatric Association meeting.
    Sen S; Prabhu M
    J Clin Psychopharmacol; 2012 Jun; 32(3):435. PubMed ID: 22561482
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.